To further substantiate this neuroimmune‐metabolic axis, we established an AAV‐mediated, pancreatic macrophage‐specific Card9 silencing strategy in NOD mice, as well as generated Card9−/− mice subjected to STZ‐induced T1D. The gene discussed is CARD9; the disease is type 1 diabetes mellitus.